Focusing technology assessment using medical decision theory.

Area of Science:

• Medical Decision Theory
• Health Technology Assessment
• Epidemiology

Background:

• Assessing the value of new diagnostic technologies is crucial for healthcare resource allocation.
• Existing methods may not adequately integrate decision theory with epidemiologic data for technology assessment.

Purpose of the Study:

• To develop and present a novel strategy for evaluating the cost-effectiveness of diagnostic technologies.
• To determine whether the expected value of diagnostic information (EVDI) justifies the deployment of a new technology.

Main Methods:

• The strategy combines medical decision theory and epidemiologic data.
• It employs a two-hurdle approach: Hurdle 1 assumes perfect diagnostic accuracy to assess global EVDI, followed by Hurdle 2 involving critical clinical studies if initial assessment is favorable.
• Relies on existing data for initial evaluation, reserving new clinical trials for later stages.

Main Results:

• The preliminary evaluation (Hurdle 1) uses published data on treatment efficacy and illness probabilities.
• If a technology fails the initial cost-effectiveness screen, its use is not recommended.
• Subsequent studies (Hurdle 2) focus on actual diagnostic accuracy to refine cost-effectiveness calculations.

Conclusions:

• The proposed strategy offers a structured, evidence-based approach to diagnostic technology assessment.
• It aims to optimize resource allocation by identifying cost-effective technologies early.
• The method reduces the need for extensive clinical trials in the initial assessment phase.